Table 1 Description of case vignettes regarding documented prescription of PIM
From: Why do family doctors prescribe potentially inappropriate medication to elderly patients?
FP | Documented chronic conditions of the case (ICD-10) | Documented acutediagnosis of the case (ICD-10) | Prescription of PIM per quarter: agents/amount (prescribed daily dosage) | Further agents for long-term treatment/same quarter |
|---|---|---|---|---|
FP1 | D25: Leiomyoma of uterus | F43: Reaction to severe stress, and adjustment disorders | Zolpidem/80 pellets (missing) | Candesartan, Carbamazepine, Doxepin, Gabapentin, Metoprolol, Metformin, Pravastatin |
E22: Hyperfunction of pituitary gland | ||||
E78: Disorders of lipoprotein metabolism | ||||
G25: Other extrapyramidal and movement disorders | ||||
G47: Sleep disorders | ||||
G56: Mononeuropathies of upper limb | ||||
G58: Other mononeuropathies | ||||
I10: Essential (primary) hypertension | ||||
I65: Occlusion and stenosis of precerebral arteries | ||||
R55: Syncope and collapse | ||||
FP2 | F13: Mental and behavioral disorders due to use of sedatives or hypnotics | M54: Dorsalgia | Zopiclone/60 pellets (7.5 mg/day), Lorazepam/missing (2.5 mg/day) | Acetylsalicylic acid, Amlodipine, Calcitrol, Carvedilol, Cholecalciferol, Minoxidil, Mirtazapine, Pantoprazole, Torasemide, Valsartan |
F34: Persistent mood [affective] disorders | ||||
F40: Phobic anxiety disorders G47: Sleep disorders | ||||
I10: Essential (primary) hypertension | ||||
N18: Chronic kidney disease | ||||
T88: Other complications of surgical and medical care, not elsewhere classified | ||||
FP3 | E03: Hypothyroidism | J06: Acute upper respiratory infections of multiple and unspecified sites | Zolpidem/80 pellets (10 mg/day) | Beclomethasone, Bisoprolol, Cobalamin, Duloxetine, Hydrochlorothiazide, Lactulose, Levothyroxine, Metoclopramide, Omeprazole, Salbutamol, Tramadol, |
E53: Deficiency of other B group vitamins | ||||
I35: Nonrheumatic aortic valve disorders I50: Heart failure | ||||
K29: Gastritis and duodenitis | ||||
M48: Other spondylopathies | ||||
Q61: Cystic kidney disease | ||||
R15: Faecal incontinence | ||||
R52: Pain, not elsewhere classified | ||||
FP4 | D86: Sarcoidosis | none | Zolpidem/100 pellets (10 mg/day) | Hydrochlorothiazide, Naloxone, Nitrendipine, Pregabalin, Tilidine, Valsartan |
E78: Disorders of lipoprotein metabolism and other lipidaemias | ||||
G47: Sleep disorders | ||||
H53: Visual disturbances | ||||
I10: Essential (primary) hypertension | ||||
I83: Varicose veins of lower extremities | ||||
M25: Other joint disorders, not elsewhere classified | ||||
M81: Osteoporosis without pathological fracture | ||||
N17: Acute renal failure | ||||
R26: Abnormalities of gait and mobility | ||||
Z93: Artificial opening status | ||||
FP5 | C80: Malignant neoplasm, without specification of site | R07: Pain in throat and chest | Zopiclone/missing (7.5 mg/day) | Bisoprolol, Hydrochlorothiazide, Ramipril, Trimipramine, Pantoprazole, Acetylsali-cylic acid, Ibuprofen |
H53: Visual disturbances | ||||
I10: Essential (primary) hypertension | ||||
I27: Other pulmonary heart diseases | ||||
I34: Atrial fibrillation and flutter | ||||
K43: Ventral hernia | ||||
R26: Abnormalities of gait and mobility | ||||
Z93: Artificial opening status | ||||
Z96: Presence of other functional implants | ||||
FP6 | E11: Type 2 diabetes mellitus | none | Zopiclon/120 pellets (missing) | Allopurinol, Amlodipine, Enalapril, Moxonidine |
I10: Essential (primary) hypertension | ||||
I50: Heart failure | ||||
M10: Gout | ||||
N08: Glomerular disorders in diseases classified elsewhere | ||||
N18: Chronic kidney disease | ||||
FP7 | E78: Disorders of lipoprotein metabolism and other lipidaemias | M54: Dorsalgia | Zopiclon/180 pellets (7.5 mg/day) | Allopurinol, Felodipine, Metoprolol, Olmesartan |
E79: Disorders of purine and pyrimidine metabolism | ||||
F51: Nonorganic sleep disorders I10: Essential (primary) hypertension | ||||
J44: Other chronic obstructive pulmonary disease |